InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by CLARKE JOHN K, Director. Director active across 2 companies, notably aTYR PHARMA INC. Aggregated, 2 disclosures have been recorded. Total volume traded: €18k. The latest transaction was filed on 21 May 2021 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€8,8752,500 shares@ €3.55100.0% of flow
Common Stock
SEC:0001209191-21-035836·
€8,8752,500 shares@ €3.550.012% mcap100.0% of flow
Common Stock
SEC:0001209191-21-035836:0·
2 of 2 declarations
About CLARKE JOHN K
John K. Clarke is a Board Member at aTYR PHARMA INC. He plays a crucial role in the strategic direction of the company, which focuses on developing treatments for rare diseases. His expertise helps guide key decisions for the company's future.
